Clinical evaluation of minimized extracorporeal circulation in high-risk coronary revascularization: impact on air handling,inflammation,hemodilution and myocardial function

Abstract

Objective: We examined intraoperative microembolic signals (GME), inflammatory response, hemolysis, perioperative regional cerebral oxygen saturation (rSO₂), myocardial protection and desorbed protein amount on oxygenator fibers in high-risk patients undergoing coronary revascularization (CABG) with minimized and conventional cardiopulmonary bypass (CPB). Methods: Over a ten-month period, 40 Euroscore 6+ patients undergoing CABG were prospectively randomized to one of the two perfusion protocols (N=20): Group 1: minimized extracorporeal circuits (Mini-CPB) (ROCsafe MPC, Terumo, Ann Arbor, MI, USA) and Group 2: conventional extracorporeal circuits (CECC) (Capiox SX18, Terumo, USA). Serum creatinine kinase-MB (CKMB), free hemoglobin, interleukin-6 (IL-6) and C3a levels were measured. Blood samples were collected at T1: following induction of anesthesia; T2: thromboelastography control; T3:15 min after commencement of CPB; T4: before cessation of CPB; T5: 15 min after protamine reversal and T6: ICU. Results: Serum IL-6 levels were significantly lower in the Mini-CPB group at T4 and T5 and C3a levels were significantly less in the Mini-CPB group at T3, T4 and T5 vs. CECC (p<0.01). CKMB levels in coronary sinus blood demonstrated well preserved myocardium in the Mini-CPB group. Percentage expression of neutrophil CD11b/CD18 levels were significantly lower in the Mini-CPB group at T4 and T5 (p<0.05). There were no significant differences in air handling characteristics or free plasma hemoglobin levels in either circuit. rSO₂ measurements were significantly better at T3 and T4 in the Mini-CPB vs. CECC (p<0.05) and always higher in the Mini-CPB during follow-up. Blood protein adsorption analysis of oxygenator membranes demonstrated a significantly increased amount of microalbumin on CECC fibers (p<0.05). Conclusion: Mini-CPB provided a comfort and safety level similar to conventional control via satisfactory air handling, attenuated inflammatory response and hemodilution, with a better clinical outcome in patients undergoing high-risk CABG.

Keywords

Cardiopulmonary bypass CPB-inflammatory response minimal extracorporeal circulation

Get full access to this article

View all access options for this article.

References

Mulholland JW , Anderson JR , Yarham GJ , Tuladhur S. , Saed I. , Oliver MD Miniature cardiopulmonary bypass-the Hammersmith experience. Perfusion 2007; 22(3): 161-166.

Immer FF , Ackermann A. , Gygax E. , et al. Minimal extracorporeal circulation is a promising technique for coronary artery bypass grafting. Ann Thorac Surg 2007; 84: 1515-1521.

Perthel M. , Kseibi S. , Sagebiel F. , Alken A. , Laas J. Comparison of conventional extracorporeal circulation and minimal extracorporeal circulation with respect to microbubbles and microembolic signals. Perfusion 2005; 20(6): 329-333.

Repo H. , Jansson SE , Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164: 193-202.

Gunaydin S. Air handling and cardiac surgery: EDAC® quantifier introduces new concepts in solving an old problem. AmSECT Today 2008 ; 11(10): 11.

Tanaka M. , Motomura T. , Kawada M. et al. Blood compatible aspects of poly(2-methoxyethylacrylate) relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000; 21: 1471-1481.

Levy JH , Tanaka KA Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003; 75: S715-S720.

Zamora E. , Delgado L. , Castro MA , et al. Coronary artery bypass surgery using the mini-extracorporeal circulation system: a Spanish unit’s experience. Rev Esp Cardiol 2008; 61(4): 376-381.

Moen O. , Fosse E. , Dregelid E. , et al. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 1996 ; 62: 1134-1140.

10.

Nishida H. , Aomi S. , Tomizawa Y. , et al. Comparative study of biocompatibility between open circuit and closed circuit in cardiopulmonary bypass. Artif Organs 1999; 23:547-551.

11.

Nollert G. , Schwabenland I. , Maktav D. , et al. Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal ımpact on ınflammation and coagulation but loss of safety margins. Ann Thorac Surg 2005 ; 80: 2326-2332.

12.

van Boven WJ , Gerritsen WB , Waanders FG , Haas FJ , Aarts LP Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function. Perfusion 2004; 19: 239-246.

13.

McCusker K. , Vijay V. , DeBois W. , Helm R. , Sisto D. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion 2001; 16(6): 447-452.

14.

Fransen EJ , Ganushchak YM , Vijay V. , de Jong DS , Buurman WA , Maessen JG Evaluation of a new condensed extracorporeal circuit for cardiac surgery: a prospective randomized clinical pilot study. Perfusion 2005; 20: 91-99.

15.

Farneti PA , Sbrana S. , Spiller D. , et al. Reduction of blood coagulation and monocyte-platelet interaction following the use of a minimal extracorporeal circulation system (Synergy®) in coronary artery bypass grafting. Perfusion 2008; 23: 49-56.

16.

Ohata T. , Mitsuno M. , Yamamura M. , et al. Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting. J Artif Organs 2007; 10: 92-95.

17.

Gourlay T. , Samartzis I. , Taylor KM The effect of haemodilution on blood/biomaterial contact-mediated CD11b expression on neutrophils: ex vivo studies. Perfusion 2003; 18: 87-93.

18.

Huybregts RAJM, Morariu AM , Rakhorst G. , et al. Attenuated renal and ıntestinal ınjury after use of a mini-cardiopulmonary bypass system. Ann Thorac Surg 2007; 83: 1760-1767.

19.

McCusker K. , Chalafant A. , de Foe G. , Gunaydin S. , Vijay V. Influence of hematocrit and pump prime on cerebral oxygen saturation in on-pump coronary revascularization. Perfusion 2006; 21(3): 149-55.

20.

Gunaydin S. , McCusker K. , Vijay V. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits. J Extracorp Technol 2005; 37(3): 290-295.

21.

Gunaydin S. Clinical significance of coated extracorporeal circuits: a review of novel technologies. Perfusion 2004; 19: S33-S41.

22.

Gunaydin S. , Farsak B. , Kocakulak M. , Sari T. , Yorgancioglu C. , Zorlutuna Y. Clinical performance and biocompatibility of poly (2-methoxyethylacrylate) coated extracorporeal circuits. Ann Thorac Surg. 2002; 74(3): 819-824.